Connective Tissue Gene Tests has released five new tests for mutations, deletions, or duplications in genes related to connective tissue disorders.
The company now tests genes related to familial thoracic aortic aneurysm, Loeys-Dietz syndrome, proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, thrombocytopenia and absent radius syndrome, and Wilson disease.
CTGT runs its new tests on its High-Density Targeted Array for copy number variation detection. The HDT array is manufactured by Agilent Technologies.
Cytoo will later this month launch CytooPlates Motility, a new product to study cell migration for screening applications in both oncology and drug discovery.
Cytoo launched its CytooChips Motility product last year. Using the 2-cm-by-2-cm chips, users can track cell migration on one-dimensional adhesive lines and in two-dimensional areas on the same surface. Each chip contains 192 lines. According to the company, the line topology on the chips can be used for a number of applications, including controlled cell division studies and bidirectional neurite outgrowth.
In comparison, the new CytooPlates Motility product offers users access to a hundred lines printed in each microplate well of a 96-well plate. On each line, multiple cells can migrate, according to the firm, allowing users to test in parallel different compounds or conditions and monitor changes in morphology, protein trafficking, localization, and intensity.
BioArray News spoke with company spokesperson Chloe Loiraud about the new offering in October (BAN 10/23/2012).